S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:55 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead

BMY

BRISTOL MYERS SQUIBB CO
NYSE · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
66.82
−1.27 −1.87%
USD · close Sep 4
MKT CAP $136.5BP/E 14.7DIV YIELD FCF YIELD 8.38%REV TTM $49.2B +3.1%NET INCOME $9.3B +83.8%NET DEBT $34.1B52W 42.60 – 68.09SEC XBRL · TTM TO Invalid Date

Financials

SEC XBRL · 62 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q2 2026 · Jun 30$13B+5.7%71.3%$3.3B+153.2%1.62$3.4B$305M$3.1BJul 30
Q1 2026 · Mar 31$11.5B+2.6%70.2%$2.7B+9.0%1.31$1.1B$347M$757MJul 30
Q4 2025 · Dec 31derived$12.5B+1.3%67.2%$1.1B+1409.7%0.53$2B$370M$1.6BFeb 11
Q3 2025 · Sep 30$12.2B+2.8%71.9%$2.2B+81.8%1.08$6.3B$320M$6BOct 30
Q2 2025 · Jun 30$12.3B+0.6%72.5%$1.3B−22.0%0.64$3.9B$361M$3.6BJul 30
Q1 2025 · Mar 31$11.2B−5.6%72.9%$2.5B1.20$2B$260M$1.7BJul 30
Q4 2024 · Dec 31derived$12.3B+7.5%61.0%$72M−95.9%0.04$4.4B$378M$4.1BFeb 11
Q3 2024 · Sep 30$11.9B+8.4%75.1%$1.2B−37.2%0.60$5.6B$324M$5.3BOct 30
Q2 2024 · Jun 30$12.2B73.2%$1.7B0.83$2.3B$262M$2.1BOct 30
Q1 2024 · Mar 31$11.9B75.3%−$11.9B-5.89$2.8B$284M$2.5BOct 30
Q4 2023 · Dec 31derived$11.5B76.1%$1.8B0.87$4.3B$330M$3.9BFeb 11
Q3 2023 · Sep 30$11B77.1%$1.9B0.93$4.8B$342M$4.4BOct 31

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2025 · to Dec 31$48.2B71.1%$7.1B14.6%3.46$14.2B$1.3B$12.8B$0$5B
FY2024 · to Dec 31$48.3B71.1%−$8.9B-18.5%-4.41$15.2B$1.2B$13.9B$0$4.9B
FY2023 · to Dec 31$45B76.2%$8B17.8%3.86$13.9B$1.2B$12.7B$5.2B$4.7B
FY2022 · to Dec 31$46.2B78.0%$6.3B13.7%2.95$13.1B$1.1B$11.9B$8B$4.6B
FY2021 · to Dec 31$46.4B78.6%$7B15.1%3.12$16.2B$973M$15.2B$6.3B$4.4B
FY2020 · to Dec 31$42.5B72.3%−$9B-21.2%-3.99$14.1B$753M$13.3B$1.5B$4.1B

Every number comes from BRISTOL MYERS SQUIBB CO's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch BMY. Know when insiders buy.
One email the day a filing lands. Free.